Four-days-on, three-days-off treatment regimen still looks effective after two years
Similar rate of severe clinical outcomes with two drug vs three drug HIV treatment combinations
Islatravir plus doravirine remains effective at 96 weeks
Long-acting injectables might be administered every two months
Options for two-drug simplification expand
Dolutegravir dual therapy works well for both first line and maintenance treatment
Islatravir plus doravirine may offer new dual therapy option
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds
US regulators approve new two-drug combination pill for HIV
